News Headlines Article

FDA approves Pfizer drug for rare blood cancer
USA Today

The Food and Drug Administration on Tuesday approved a new Pfizer drug to treat a rare form of blood and bone marrow cancer that causes a buildup of unhealthy white blood cells. Pfizer’s Bosulif is a daily pill to treat chronic myeloid leukemia patients who carry a specific genetic variation. The disease is one of four types of the blood cancer, and accounts for about 15% of leukemia cases.

Commands